Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CYP3A4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MFAP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
FUT10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CERS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APOA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC142 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF281 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OSBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCSTN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFP91 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM234B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZCCHC17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01197 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on